tiprankstipranks
Pharming Group N.V. (PHGUF)
:PHGUF
US Market

Pharming Group (PHGUF) Financial Statements

Compare
92 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently $620.25M. The company's EPS TTM is $-0.025; its P/E ratio is ―; Pharming Group is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 220.10M$ 188.06M$ 177.73M$ 188.63M$ 147.67M
Operating Income$ -24.07M$ 3.76M$ 10.93M$ 74.44M$ 60.91M
EBITDA-$ 24.22M$ 38.24M$ 50.27M$ 63.77M
Net Income$ -10.55M$ 13.72M$ 15.96M$ 37.73M$ 36.20M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 462.85M$ 425.80M$ 397.31M$ 418.45M$ 228.21M
Total Debt$ 171.54M$ 166.69M$ 161.76M$ 161.96M$ 51.90M
Net Debt$ -41.88M$ 163.79M$ 153.11M$ 154.84M$ -14.40M
Total Liabilities$ 244.07M$ 242.90M$ 233.04M$ 274.21M$ 123.53M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -18.77M$ 21.06M$ 27.14M$ 78.93M$ 43.79M
Operating Cash Flow$ -17.30M$ 22.46M$ 37.84M$ 83.63M$ 66.50M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis